T. Rowe Price reports 4.1% stake in Zimmer Biomet

Zimmer Biomet Holdings Inc. ownership disclosure: T. Rowe Price Associates, Inc. reports beneficial ownership of 7,997,806 shares of Common Stock, representing 4.1% of the class as shown in the amendment.

Rhea-AI Filing Summary

Zimmer Biomet Holdings Inc. ownership disclosure: T. Rowe Price Associates, Inc. reports beneficial ownership of 7,997,806 shares of Common Stock, representing 4.1% of the class as shown in the amendment. The filing lists 7,523,342 shares with sole voting power and 7,997,806 shares with sole dispositive power.

The cover shows 03/31/2026 and the filing is signed on 05/15/2026.

Insights

Equity Ownership Analyst

T. Rowe Price holds a sub-5% stake in Zimmer Biomet with sole voting and dispositive control reported.

T. Rowe Price Associates, Inc. reports 7,997,806 shares beneficially owned (4.1%) with 7,523,342 shares of sole voting power and 7,997,806 shares of sole dispositive power. The amendment is dated 03/31/2026 and signed 05/15/2026.

The filing includes a standard non‑admission clause denying beneficial ownership. Subsequent filings or proxy materials would be required to show any change in voting position or intentions.

Key Figures

Beneficial ownership: 7,997,806 shares Percent of class: 4.1% Sole voting power: 7,523,342 shares +4 more

7 metrics

Beneficial ownership 7,997,806 shares reported amount

Percent of class 4.1% percentage of class reported

Sole voting power 7,523,342 shares sole power to vote as reported

Sole dispositive power 7,997,806 shares sole power to dispose as reported

CUSIP 98956P102 security identifier for Common Stock

Report period 03/31/2026 cover date shown on amendment

Signature date 05/15/2026 date signed by Ellen York, Vice President

Key Terms

Schedule 13G/A, Beneficial ownership, Sole Dispositive Power, CUSIP

4 terms

Schedule 13G/A regulatory

"Amendment No. 1 ) ZIMMER BIOMET HOLDINGS INC"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership regulatory

"Amount beneficially owned: 7997806"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole Dispositive Power financial

"Sole power to dispose or to direct the disposition of: 7997806"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

CUSIP technical

"CUSIP No.: 98956P102"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does T. Rowe Price (ZBH) report?

T. Rowe Price reports beneficial ownership of 7,997,806 shares, equal to 4.1% of the class. The amendment lists sole voting power of 7,523,342 and sole dispositive power of 7,997,806 in the disclosed position.

What dates are on the Schedule 13G/A for ZBH?

The cover shows the reporting period date 03/31/2026 and the filing is signed on 05/15/2026. These dates indicate the reported position and the signature date of the amendment.

Does the filing show shared voting or dispositive power?

No; the filing reports 0 shares of shared voting power and 0 shared dispositive power. All voting and dispositive power in this filing are reported as sole powers by the filer.

Does T. Rowe Price admit beneficial ownership in this filing?

No; the filing includes a declaratory clause denying beneficial ownership. The filer states the filing "shall not be construed as an admission" that it is the beneficial owner of the securities.

What is the CUSIP and class reported in the amendment?

The filing lists the security as Common Stock with CUSIP 98956P102. The reported class and CUSIP identify the specific equity security referenced in the Schedule 13G/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 10:07 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

ZIMMER BIOMET HOLDINGS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

98956P102

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 98956P102

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,523,342.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,997,806.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,997,806.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ZIMMER BIOMET HOLDINGS INC
(b)	Address of issuer's principal executive offices: 345 EAST MAIN STREET, WARSAW, IN, 46580
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 98956P102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 7997806
(b)	Percent of class: 4.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 7523342
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 7997806
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	05/15/2026